Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Acurx Pharmaceuticals, Inc. (ACXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results|
Docs:
|
"CONDENSED INTERIM BALANCE SHEETS June 30, December 31, 2023 2022 ASSETS CURRENT ASSETS Cash $ 9,145,835 $ 9,111,751 Prepaid Expenses 89,942 264,955 TOTAL ASSETS $ 9,235,777 $ 9,376,706 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES Accounts Payable and Accrued Expenses $ 3,019,408 $ 2,061,685 TOTAL CURRENT LIABILITIES 3,019,408 2,061,685 TOTAL LIABILITIES 3,019,408 2,061,685 COMMITMENTS AND CONTINGENCIES SHAREHOLDERS' EQUITY Common Stock; $.001 par value, 200,000,000 shares authorized, 13,005,128 and 11,627,609 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 13,005 11,628 Additional Paid-In Capital 51,192,646 45,944,478 Accumulated Deficit TOTAL SHAREHOLDERS’ EQUITY 6,216,369 7,315,021 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 9,235,777 $ 9..." |
|
| 11/14/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 11/16/2021 |
8-K
| Quarterly results|
Docs:
|
"ACURX PHARMACEUTICALS, INC. CONDENSED INTERIM STATEMENTS OF OPERATIONS Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 OPERATING EXPENSES Research and Development $ 1,126,972 $ 659,977 $ 1,313,954 $ 1,745,446 General and Administrative 3,515,250 654,569 8,873,160 1,761,561 TOTAL OPERATING EXPENSES 4,642,222 1,314,546 10,187,114 3,507,007 Gain on forgiveness of Paycheck Protection Program Loan — — 66,503 — NET LOSS $ $ $ $ LOSS PER SHARE Basic and diluted net loss per common share/units $ $ $ $ Weighted average pro forma shares outstanding basic and diluted 10,116,403 6,266,584 7,988,563 6,037,254 ACURX PHARMACEUTICALS, INC. CONDENSED INTERIM BALANCE SHEETS" |
|
| 08/16/2021 |
8-K
| Quarterly results|
Docs:
|
"ACURX PHARMACEUTICALS, INC. CONDENSED INTERIM BALANCE SHEETS June 30, December 31, 2021 2020 ASSETS CURRENT ASSETS Cash $ 17,095,596 $ 3,175,411 Prepaid Expenses 344,549 48,609 TOTAL ASSETS $ 17,440,145 $ 3,224,020 LIABILITIES AND MEMBERS' AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts Payable and Accrued Expenses $ 1,918,639 $ 455,931 Paycheck Protection Program Loan - 16,625 TOTAL CURRENT LIABILITIES 1,918,639 472,556 NONCURRENT LIABILITIES Paycheck Protection Program Loan - 49,878 TOTAL LIABILITIES 1,918,639 522,434 COMMITMENTS AND CONTINGENCIES MEMBERS' AND SHAREHOLDERS' EQUITY Members' Equity, Class A - 16,402,198 Members' Equity, Class B - 100,000 Common Stock; $.001 par value, 200,000,000 shares authorized, 9,916,208 shares issued and outstanding at June 30, 2021 9,916 - Addi..." |
|
|
|